Does Fatty Liver Cause Hot Flashes?

Does fatty liver cause hot flashes? While no direct causal link has been established by NICE or the NHS, fatty liver disease and vasomotor symptoms such as hot flashes often occur together, particularly in women going through perimenopause and menopause. Both conditions share common metabolic risk factors, including obesity, insulin resistance, and hormonal changes, which may explain why they frequently coincide. Understanding the relationship between liver health and hormonal balance can help you recognise when to seek medical advice and what investigations may be appropriate.

Can fatty liver disease actually cause hot flashes?

Fatty liver disease does not directly cause hot flashes; any association likely reflects shared metabolic risk factors such as obesity and insulin resistance rather than a direct causal pathway.

Fatty liver disease does not directly cause hot flashes, and no official clinical link has been established by NICE or the NHS stating that it does. Hot flashes are primarily driven by hormonal changes, particularly falling oestrogen levels during perimenopause and menopause, rather than by liver dysfunction itself.^[1][2] Any relationship between fatty liver and vasomotor symptoms such as hot flashes and night sweats is likely to reflect shared underlying metabolic risk factors rather than a direct causal pathway.

Non-alcoholic fatty liver disease (NAFLD), which is increasingly referred to in research literature as metabolic dysfunction-associated steatotic liver disease (MASLD), is one of the most common liver conditions in the UK.^[8][9] UK guidance, including NICE and NHS resources, still predominantly uses the term NAFLD, and both terms refer to the same spectrum of liver disease. NAFLD is closely linked to obesity, insulin resistance, and metabolic syndrome, all of which can independently influence hormone levels and temperature regulation.^[4][5]

Because the liver plays a central role in metabolising hormones, a liver that is not functioning optimally may potentially alter hormonal balance in ways that could contribute to vasomotor symptoms, though this mechanism remains theoretical and is not established in UK clinical guidance. If you are experiencing both hot flashes and symptoms that might suggest liver involvement, this warrants a conversation with your GP rather than self-diagnosis, as the two conditions may share common underlying causes.

How are the liver and hormonal balance connected?

The liver metabolises oestrogen and produces SHBG, which regulates free hormone levels; fatty liver may reduce this efficiency, though a direct link to vasomotor symptoms is not clinically established.

The liver is central to hormonal balance because it is responsible for metabolising and clearing hormones, including oestrogen, from the bloodstream. When the liver is burdened by excess fat or inflammation, its ability to process hormones efficiently may be reduced. In the context of perimenopause and menopause, where oestrogen levels are already falling, any additional disruption to hormone metabolism could theoretically alter the bioavailability of sex hormones, though this link is not firmly established in clinical evidence.

The liver also produces sex hormone-binding globulin (SHBG), a protein that regulates how much free oestrogen and testosterone circulate in the body.^[11][12] Research has shown that people with fatty liver disease often have lower SHBG levels, which can alter the balance of active hormones in the bloodstream.^[13][14] Lower SHBG is associated with higher free androgen activity and changes in oestrogen bioavailability, which may influence mood, body temperature regulation, and other hormonal symptoms. However, these associations are observational and do not confirm that fatty liver directly causes vasomotor symptoms.

Chronic low-grade inflammation, which is a hallmark of NAFLD and MASLD, may also affect the hypothalamus, the part of the brain that controls body temperature. Disruption to hypothalamic signalling is thought to contribute to hot flashes in menopausal women, with the neurokinin B pathway playing a central role following oestrogen withdrawal.^[16][17] Whether liver-related inflammation meaningfully contributes to this pathway in practice remains an area of ongoing research rather than established fact.

Understanding these potential connections highlights why liver health should not be viewed in isolation. Supporting liver function through diet, physical activity, and appropriate medical management is consistent with UK guidance on NAFLD management (NICE NG49) and may have broader benefits for overall metabolic wellbeing, though it should not be presented as a treatment for vasomotor symptoms.

Could menopause and fatty liver be affecting you at the same time?

Yes, menopause and fatty liver frequently co-occur because declining oestrogen increases susceptibility to NAFLD, and both conditions share the same metabolic risk factors such as central adiposity and insulin resistance.

Menopause and fatty liver disease frequently occur together, and there is evidence that the relationship runs in at least one direction: oestrogen has a protective effect on the liver, helping to regulate fat metabolism and reduce inflammation.^[20] As oestrogen levels decline during perimenopause and menopause, women become more susceptible to developing or worsening fatty liver disease. Observational studies suggest that the prevalence of NAFLD increases after the menopause transition, which is consistent with the known metabolic effects of oestrogen loss.^[20]

The metabolic changes associated with menopause, including increased central adiposity (fat around the abdomen), insulin resistance, and changes in lipid profiles, are the same risk factors that drive fatty liver disease. This means that a woman experiencing hot flashes, weight gain around the middle, fatigue, and disrupted sleep may be dealing with both conditions simultaneously without realising it.

If you are in your 40s or 50s and experiencing hot flashes alongside unexplained fatigue, abdominal discomfort, or elevated liver enzymes on a blood test, it is worth discussing both menopause and liver health with your GP. In line with NICE guidance on menopause (NG23), the diagnosis of menopause in women aged 45 and over is made clinically, based on symptoms, without the need for routine blood tests.^[3] Hormonal blood tests such as FSH may be considered in women aged 40 to 45 with menopausal symptoms, or where the diagnosis is uncertain, but are not routinely recommended for women over 45.^[3] Liver function tests are a straightforward investigation that can be requested alongside any relevant assessment.

Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online consultations with prescriber review and pharmacist support. Medicines, including any prescription-only treatments, are only prescribed where clinically appropriate following a consultation.

What other symptoms suggest your liver may be struggling?

Persistent fatigue, upper right abdominal discomfort, nausea, and elevated liver enzymes on blood tests may indicate liver involvement, though many of these features are non-specific and require GP investigation.

Fatty liver disease is often described as a silent condition because many people have no obvious symptoms in its early stages, and liver function tests can be normal even when significant fat accumulation is present.^[21][22] However, as the condition progresses, a range of symptoms may emerge that suggest the liver is under strain. It is also worth noting that some of the features below are non-specific and can have many causes, so they should prompt investigation rather than self-diagnosis.

Recognised features that may be associated with liver involvement include:

• Persistent fatigue that is disproportionate to activity levels and does not improve with rest

• Discomfort or a dull ache in the upper right side of the abdomen, where the liver sits

• Nausea or a general feeling of being unwell, though this is non-specific and not a defining feature of NAFLD

• Elevated liver enzymes (ALT or AST) found incidentally on routine blood tests, though normal results do not exclude NAFLD

In more advanced liver disease, symptoms can include jaundice (yellowing of the skin or whites of the eyes), dark urine, pale stools, and significant swelling of the abdomen. These are signs that require prompt medical attention.

It is worth noting that fatigue is also a common menopausal symptom, which can make it difficult to distinguish between the two conditions without appropriate testing. A GP can arrange liver function tests and, where indicated, calculate a FIB-4 score (a simple calculation using age, liver enzyme levels, and platelet count) to assess the risk of significant liver fibrosis, in line with NICE NG49.^[4][5] If the FIB-4 result is indeterminate or suggests higher risk, further assessment using enhanced liver fibrosis (ELF) testing or referral to hepatology may be recommended.^[6][23] An abdominal ultrasound may also be arranged, though it may not detect mild steatosis. Early identification of fatty liver disease is important because lifestyle changes, particularly dietary modification and increased physical activity, can significantly reduce liver fat and improve overall metabolic health.^[7][24]

When should you speak to a GP about hot flashes and liver health?

Speak to your GP if hot flashes significantly affect your quality of life or are accompanied by fatigue, abdominal discomfort, elevated liver enzymes, or metabolic risk factors such as type 2 diabetes or obesity.

You should speak to your GP if hot flashes are significantly affecting your quality of life, particularly if they are accompanied by other symptoms that could suggest an underlying liver or metabolic condition. There is no need to wait until symptoms become severe. Early assessment allows for timely investigation and, where appropriate, management of both hormonal and liver-related concerns.

Consider contacting your GP if you experience any of the following:

• Hot flashes or night sweats that are frequent, severe, or disrupting sleep

• Unexplained fatigue or abdominal discomfort alongside vasomotor symptoms

• A previous blood test showing elevated liver enzymes, even if you were told to monitor rather than treat

• A diagnosis of type 2 diabetes, obesity, or metabolic syndrome, which increases the risk of NAFLD

• A family history of liver disease

• Symptoms of jaundice, significant abdominal swelling, or very dark urine, which require same-day assessment

For urgent symptoms such as sudden severe abdominal pain, confusion, or rapidly developing jaundice, contact NHS 111 for advice on the appropriate next steps. If you are experiencing a life-threatening emergency, call 999 or go to your nearest A&E department.

Your GP can arrange liver function tests and, where appropriate, calculate a FIB-4 score as part of a structured NAFLD assessment in line with NICE NG49. If fibrosis risk is indeterminate or elevated, ELF testing or hepatology referral may follow. For menopause, NICE NG23 recommends a clinical diagnosis in women aged 45 and over based on symptoms alone, without routine hormonal blood tests. FSH testing may be considered in women aged 40 to 45 with menopausal symptoms, or where the diagnosis is uncertain. Managing metabolic risk factors, including weight, physical activity, and diet, is central to both conditions and is the first-line approach recommended by UK guidance.

Scientific References

1. Symptoms of menopause and perimenopause.
2. Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages.
3. Menopause: identification and management (NG23) — Recommendations.
4. Metabolic dysfunction-associated steatotic liver disease (MASLD): assessment and management (NG49).
5. MASLD: assessment and management (NG49) — full guideline PDF.
6. MASLD: assessment and management (NG49) — recommendations for research.
7. Non-alcoholic fatty liver disease (NAFLD).
8. Metabolic Dysfunction-Associated Steatotic Liver Disease, Recent Revision of Terminology and Its Implications. Korean Journal of Gastroenterology.
9. Current Update on Nomenclature, Diagnosis, and Management of Metabolic Dysfunction-associated Steatotic Liver Disease: Radiologists' Perspective. Radiographics.
10. Cost Effectiveness of Diagnosis and Screening Methods in Nonalcoholic Fatty Liver Disease: A Systematic Review. International Journal of Preventive Medicine.
11. Plasma steroid-binding proteins: primary gatekeepers of steroid hormone action. Journal of Endocrinology.
12. Synthesis and regulation of sex hormone-binding globulin in obesity. International Journal of Obesity.
13. Testosterone, Sex Hormone-Binding Globulin and Nonalcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis. Annals of Hepatology.
14. Associations of Sex Steroids and Sex Hormone-Binding Globulin with Non-Alcoholic Fatty Liver Disease: A Population-Based Study and Meta-Analysis. Genes.
15. Association of sex hormones with non-alcoholic fatty liver disease: An observational and Mendelian randomization study. Liver International.
16. Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes. The Lancet.
17. Neurokinin receptor antagonists for vasomotor symptoms: from KNDy neurons to clinical translation. Nature Reviews Endocrinology.
18. A New Hope for Women with Vasomotor Symptoms: Neurokinin B Antagonists. Journal of Clinical Medicine.
19. Non-hormonal pharmacological interventions for managing vasomotor symptoms — 2024 landscape. European Journal of Obstetrics, Gynecology, and Reproductive Biology.
20. Honokiol Improves Liver Steatosis in Ovariectomized Mice. Molecules.
21. Transaminase Concentrations Cannot Separate Non-Alcoholic Fatty Liver and Non-Alcoholic Steatohepatitis in Morbidly Obese Patients Irrespective of Histological Algorithm. Digestive Diseases.
22. Diagnostic Value of Non-invasive Liver Function Tests in Liver Fibrosis and Changes in These Parameters Post-metabolic Surgery. Obesity Surgery.
23. Comparison of Referral Rates and Costs Using Fibrosis-4 and ELF Testing. PubMed.
24. Healthy Lifestyle and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Study of the Efficacy of Fatty Liver Regression. Clinical and Translational Gastroenterology.
25. Histological improvements following energy restriction and exercise: The role of insulin resistance in resolution of MASH. Journal of Hepatology.

Frequently Asked Questions